JCO Global Oncology
Access to and Timeliness of Lung Cancer Surgery, Radiation Therapy, and Systemic Therapy in New Zealand: A Universal Health Care Context
Research paper · 2024
This document belongs to JCO Global Oncology and is held on their website. It is listed here so it can be found; it is not hosted on this site and it is not Hei Āhuru Mōwai’s work.
Read it on the publisher’s website (opens on JCO Global Oncology’s website)
Opens ascopubs.org
Which edition this is
The published version of record, JCO Global Oncology 10:e2300258, online 1 February 2024. Journal articles are not revised, so there is no later edition.
JCO Global Oncology states
Published open access under CC BY-NC-ND 4.0. The authors' own conflict-of-interest disclosures on the page include Christopher Jackson (research funding from Roche/Genentech) and Jonathan Koea (research funding, other papers in the same issue).
What this is
National-level study of all lung cancer registrations in New Zealand from 2007 to 2019 (N = 27,869), finding Māori patients less likely than European patients to access surgery, a difference only partly explained by stage and comorbidity.
A catalogue description written for this site, not JCO Global Oncology’s own words.